Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

April 21, 2006 | Customer News

ELISA automation with Tecan’s Freedom EVOlyzer®

  The Institute for Clinical Chemistry and Hematology (IKCH) in St Gallen, Switzerland is using Tecan’s new generation of ELISA automation systems, the Freedom EVOlyzer, to reduce the hands-on time of its many and varied ELISA tests.

Professor Walter Riesen, Head of IKCH, explained: “We needed an open platform that could simultaneously process multiple assays and, very importantly, it had to be able to handle short room temperature incubation times." Dr Wolfgang Korte, project leader at IKCH, elaborated: “We wanted to run a large number of different tests with only a moderate number of samples, automating as many of our applications as possible to a microtiter plate format. We needed a system that is flexible enough to handle our constantly growing and changing panel of tests."

Dr Korte concluded, "We needed an instrument that was reliable, easy to operate, provided us with clear instructions and greatly reduced hands-on time. We are confident that we have made the right choice because, once an assay is running, we can confidently leave it alone, giving us more time to spend on other tasks."

About Tecan

Tecan (www.tecan.com) is a leading global player in the Life Sciences supply industry specializing in the development, production, and distribution of advanced automation solutions enabling pharma and academic research, diagnostics, food and veterinary research as well as forensics. Through its REMP subsidiary (www.remp.com), Tecan is the leading supplier of compound and sample storage, management and logistics solutions. Tecan clients are pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2005, Tecan achieved sales of CHF 344.9 million (USD 275.9 Mio.; EUR 222.5 Mio.). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor: 1210019).

For further information please contact:

Tecan Switzerland AG
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12